176 related articles for article (PubMed ID: 30808269)
1. Vancomycin-Associated Acute Kidney Injury in Critically Ill Adolescent and Young Adult Patients.
Hays WB; Tillman E
J Pharm Pract; 2020 Dec; 33(6):749-753. PubMed ID: 30808269
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients.
Moffett BS; Hilvers PS; Dinh K; Arikan AA; Checchia P; Bronicki R
Congenit Heart Dis; 2015; 10(1):E6-10. PubMed ID: 24934335
[TBL] [Abstract][Full Text] [Related]
3. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
[TBL] [Abstract][Full Text] [Related]
4. Acute kidney injury during vancomycin therapy in critically ill children.
Totapally BR; Machado J; Lee H; Paredes A; Raszynski A
Pharmacotherapy; 2013 Jun; 33(6):598-602. PubMed ID: 23526674
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors of acute kidney injury associated with continuous intravenous high-dose vancomycin in critically ill patients: A retrospective cohort study.
Lacave G; Caille V; Bruneel F; Palette C; Legriel S; Grimaldi D; Eurin M; Bedos JP
Medicine (Baltimore); 2017 Feb; 96(7):e6023. PubMed ID: 28207512
[TBL] [Abstract][Full Text] [Related]
6. Association between trough serum vancomycin concentration and vancomycin-associated acute kidney injury and 30-day mortality in critically ill elderly adults.
Chen J; Lin J; Weng J; Ju Y; Li Y
BMC Infect Dis; 2024 Mar; 24(1):330. PubMed ID: 38509460
[TBL] [Abstract][Full Text] [Related]
7. The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin-Tazobactam or Cefepime.
Molina KC; Barletta JF; Hall ST; Yazdani C; Huang V
J Intensive Care Med; 2020 Dec; 35(12):1434-1438. PubMed ID: 30741072
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.
Robertson AD; Li C; Hammond DA; Dickey TA
Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410
[TBL] [Abstract][Full Text] [Related]
9. Polymyxin-B and vancomycin-associated acute kidney injury in critically ill patients.
Soares DS; Reis ADF; Silva Junior GBD; Leite TT; Parente Filho SLA; Rocha CVO; Daher EF
Pathog Glob Health; 2017 May; 111(3):137-142. PubMed ID: 28353411
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals.
Ramírez E; Jiménez C; Borobia AM; Tong HY; Medrano N; Krauel-Bidwell L; Carcas AJ; Selgas R; Frías J
Ther Drug Monit; 2013 Jun; 35(3):360-6. PubMed ID: 23666575
[TBL] [Abstract][Full Text] [Related]
11. Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.
Holsen MR; Meaney CJ; Hassinger AB; Fusco NM
Pediatr Crit Care Med; 2017 Dec; 18(12):e585-e591. PubMed ID: 28906422
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study.
de Almeida CDC; Simões E Silva AC; de Queiroz Oliveira JA; Batista ISF; Pereira FH; Gonçalves JE; Nobre V; Martins MAP
PLoS One; 2019; 14(9):e0222095. PubMed ID: 31487314
[TBL] [Abstract][Full Text] [Related]
13. Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation.
Slater MB; Gruneir A; Rochon PA; Howard AW; Koren G; Parshuram CS
Paediatr Drugs; 2017 Feb; 19(1):59-67. PubMed ID: 27943125
[TBL] [Abstract][Full Text] [Related]
14. Attributable nephrotoxicity of vancomycin in critically ill patients: a marginal structural model study.
Arnaud FCS; Libório AB
J Antimicrob Chemother; 2020 Apr; 75(4):1031-1037. PubMed ID: 31904834
[TBL] [Abstract][Full Text] [Related]
15. Development of acute kidney injury during continuous infusion of vancomycin in septic patients.
Cianferoni S; Devigili A; Ocampos-Martinez E; Penaccini L; Scolletta S; Abdelhadii A; De Backer D; Beumier M; Jacobs F; Vincent JL; Taccone FS
Infection; 2013 Aug; 41(4):811-20. PubMed ID: 23572272
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin-induced nephrotoxicity in non-intensive care unit pediatric patients.
Kwak S; Kim JY; Cho H
Sci Rep; 2021 Oct; 11(1):20681. PubMed ID: 34667202
[TBL] [Abstract][Full Text] [Related]
17. Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children.
Joyce EL; Kane-Gill SL; Priyanka P; Fuhrman DY; Kellum JA
J Am Soc Nephrol; 2019 Nov; 30(11):2243-2251. PubMed ID: 31501354
[TBL] [Abstract][Full Text] [Related]
18. Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients.
Buhlinger KM; Fuller KA; Faircloth CB; Wallace JR
Am J Health Syst Pharm; 2019 Aug; 76(16):1204-1210. PubMed ID: 31369115
[TBL] [Abstract][Full Text] [Related]
19. Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
Navalkele B; Pogue JM; Karino S; Nishan B; Salim M; Solanki S; Pervaiz A; Tashtoush N; Shaikh H; Koppula S; Koons J; Hussain T; Perry W; Evans R; Martin ET; Mynatt RP; Murray KP; Rybak MJ; Kaye KS
Clin Infect Dis; 2017 Jan; 64(2):116-123. PubMed ID: 27986669
[TBL] [Abstract][Full Text] [Related]
20. Kidney Injury in Critically Ill Patients Treated with Vancomycin and Zosyn or an Alternative: A Systematic Review and Meta-Analysis.
Blears EE; Morris J; Popp D; Lee JO; Norbury WB
Surg Infect (Larchmt); 2022 Aug; 23(6):516-524. PubMed ID: 35736797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
